SCHEMBL19540705

SCHEMBL19540705

CC(C)(C)OC(=O)N1C[C@@H](F)C[C@H]1CNc1ccc(F)cc1[N+](=O)[O-]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.39
▸ GPR119 Q8TDV5 9/20 0.38
▸ APP P05067 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ ADRA2A P08913 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ ADRA2B P18089 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ SLC6A2 P23975 1/20 0.36
▸ HRH2 P25021 1/20 0.36
▸ HTR1D P28221 1/20 0.36
▸ HTR1B P28222 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ HTR7 P34969 1/20 0.36
▸ DRD3 P35462 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ HTR2B P41595 1/20 0.36
▸ PSEN1 P49768 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20956735 0.85 HCAR3 (0.40) MAPTMAPK1L3MBTL1TDP1BCHE
SCHEMBL23119916 0.85 HCAR3 (0.40) MAPTMAPK1L3MBTL1TDP1BCHE
SCHEMBL19540704 0.85 ECE1 (0.40) GPR119APPHTR1AADRA2ADRD2
SCHEMBL19540504 0.85 HDAC2 (0.41) APPHTR1AADRA2ADRD2ADRA2B
SCHEMBL19540689 0.84 APP (0.51) MAPTGPR119APPHTR1AADRA2A
SCHEMBL19540621 0.81 MAPT (0.38) MAPTGPR119APPHTR1AADRA2A
SCHEMBL22724881 0.80 BRD3 (0.49) MAPTGPR119
SCHEMBL29774856 0.76 TGFBR1 (0.40) CYP1A2POLBCYP3A4CYP2C19
SCHEMBL23119912 0.75 HCAR3 (0.40) MAPTMAPK1L3MBTL1TDP1BCHE
SCHEMBL16657351 0.74 MAPT (0.47) MAPTGPR119LMNAKCNMA1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017186147-A1 BENZIMIDAZOLE-LINKED INDOLE COMPOUND ACTING AS NOVEL DIVALENT IAP ANTAGONIST 南京明德新药研发股份有限公司 2017-11-02 — — WO disclosed
Send feedback